Effect of obesity on biodistribution of nanoparticles
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 281, 11-18
Abstract
No abstract availableKeywords
Funding Information
- National Scientific and Technological Research Council (400018/2016-0)
- Rio de Janeiro State Research Foundation (E-26/102.940/2012)
- Ministerio de Economía y Competitividad (MAT2012-38429-C04-01)
- Generalitat Valenciana (PROMETEO/2009/016)
This publication has 34 references indexed in Scilit:
- In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristicsJournal of Controlled Release, 2012
- Obesity and risk of vascular disease: importance of endothelium‐dependent vasoconstrictionBritish Journal of Pharmacology, 2012
- Impact of obesity on respiratory functionRespirology, 2011
- Application of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese PatientsClinical Pharmacokinetics, 2011
- Dosing dilemmas in obese childrenArchives of Disease in Childhood - Education & Practice Edition, 2010
- Effect of Obesity on the Pharmacokinetics of Drugs in HumansClinical Pharmacokinetics, 2010
- Physiology of obesity and effects on lung functionJournal of Applied Physiology, 2010
- Obesity and vascular dysfunctionPathophysiology, 2008
- Review: Thinking around abdominal obesity and cardiovascular riskBritish Journal of Diabetes, 2006
- Clinical Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 1993